Clinical, radiological, biochemical and molecular characterization of a new case with multiple mitochondrial dysfunction syndrome due to IBA57: Lysine and tryptophan metabolites as potential biomarkers-Reference-Cited by-同舟云学术

Clinical, radiological, biochemical and molecular characterization of a new case with multiple mitochondrial dysfunction syndrome due to IBA57: Lysine and tryptophan metabolites as potential biomarkers

Published:2023-09 Issue:1-2 Volume:140 Page:107710
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Wongkittichote Parith,Pantano Cassandra,Bogush Emily,Alves Cesar Augusto P.,Hong Xinying,He Miao,Demczko Matthew M.,Ganetzky Rebecca D.,Goldstein Amy

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference47 articles.

1. Mammalian iron-sulphur proteins: novel insights into biogenesis and function;Rouault;Nat. Rev. Mol. Cell Biol.,2015

2. Function and biogenesis of iron-sulphur proteins;Lill;Nature,2009

3. Mechanisms of mitochondrial Iron-sulfur protein biogenesis;Lill;Annu. Rev. Biochem.,2020

4. From the discovery to molecular understanding of cellular iron-sulfur protein biogenesis;Lill;Biol. Chem.,2020

5. The human mitochondrial ISCA1, ISCA2, and IBA57 proteins are required for [4Fe-4S] protein maturation;Sheftel;Mol. Biol. Cell,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic spectrum of iron-sulfur cluster assembly gene IBA57 mutations: c.286 T > C identified as a hotspot mutation in Chinese patients with a stable natural history;Journal of Human Genetics;2024-09-03

2. Phenotypic spectrum of iron-sulfur cluster assembly gene IBA57 mutations: c.286T>C identified as a hotspot mutation in Chinese patients with a stable natural history;2024-02-21

3. Clinical, biochemical and molecular characterization of a new case with FDX2‐related mitochondrial disorder: Potential biomarkers and treatment options;JIMD Reports;2024-01-23

4. Advancing the neuroimaging diagnosis and understanding of mitochondrial disorders;Neurotherapeutics;2024-01